| Application no. and date | 14853023.1 (espacenet) (Federated) (European Patent Register), 20141010 | | Patent/reg. no. and date | DK/EP 3054976, 20200708 | | Publication date | 20160817 | | Priority no. and date | US 201361889421 P, 20131010 | | EP pub. no. and date |
EP 3054976 20160817 | | Effective date | | | Applicant/owner | Vaccinex, Inc., 1895 Mt. Hope Avenue
Rochester, NY 14620, US | | Applicant ref. no. | 1562760 | | Inventor | ZAUDERER, Maurice, 44 Woodland Road
Pittsford, New York 14534, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/395 (2006.01) | | Title | ANVENDELSE AF SEMAPHORIN-4D-BINDENDE MOLEKYLER TIL BEHANDLING AF ATEROSKLEROSE | | Int. application no. | US2014060129 | | Int. publication no. | WO2015054628 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
